Quadrant Capital Group
CSII

Quadrant Capital Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

Quadrant Capital Group’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,360
Closed -$46.9K – 2819
2023
Q1 		$46.9K Sell
2,360
-633
-21% -$10.9K ﹤0.01% 1272
2022
Q4 		$40.8K Buy
2,993
+1,921
+179% +$26.7K ﹤0.01% 1287
2022
Q3 		$15K Buy
1,072
+917
+592% +$13.6K ﹤0.01% 1712
2022
Q2 		$2K Sell
155
-225
-59% -$3.9K ﹤0.01% 2298
2022
Q1 		$9K Buy
+380
New +$7.38K ﹤0.01% 1725
2021
Q4 		– Sell
-356
Closed -$12K – 2760
2021
Q3 		$12K Sell
356
-2
-0.6% -$75 ﹤0.01% 1512
2021
Q2 		$15K Hold
358
– – ﹤0.01% 1369
2021
Q1 		$14K Buy
358
+5
+1% +$213 ﹤0.01% 1365
2020
Q4 		$15K Sell
353
-66
-16% -$2.48K ﹤0.01% 1219
2020
Q3 		$16K Sell
419
-18
-4% -$581 ﹤0.01% 1056
2020
Q2 		$14K Sell
437
-1,050
-71% -$39.2K ﹤0.01% 1212
2020
Q1 		$53K Sell
1,487
-144
-9% -$6.07K 0.01% 866
2019
Q4 		$78K Buy
1,631
+592
+57% +$27K 0.01% 1111
2019
Q3 		$49K Hold
1,039
– – 0.01% 1233
2019
Q2 		$44K Buy
+1,039
New +$40.3K 0.01% 1276

Other funds holding CSII

UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Huntington National Bank
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Quadrant Capital Group's CSII Position: Q2 2023 in Review

Quadrant Capital Group sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 2,360 shares — an estimated $46.9K sold.

Quadrant Capital Group first reported a position in CSII in Q2 2019 and held it in 15 quarters. The position peaked at $78K in Q4 2019. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • Quadrant Capital Group reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • Quadrant Capital Group sold 2,360 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $46.9K.
  • Quadrant Capital Group first reported a position in Cardiovascular Systems, Inc. in Q2 2019 and held it in 15 quarters.
  • Quadrant Capital Group's Cardiovascular Systems, Inc. position peaked at $78K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Quadrant Capital Group's 13F filing for Q2 2023, filed 10 Aug 2023.